NYSEAMERICAN:KNW Know Labs (KNW) Stock Price, News & Analysis → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free KNW Stock Alerts $0.66 +0.01 (+1.38%) (As of 11:59 AM ET) Add Compare Share Share Today's Range$0.66▼$0.7050-Day Range N/A52-Week Range$0.23▼$1.48Volume16,835 shsAverage Volume116,885 shsMarket Capitalization$56.44 millionP/E RatioN/ADividend YieldN/APrice Target$1.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest Get Know Labs alerts: Email Address Know Labs MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside51.5% Upside$1.00 Price TargetShort InterestHealthy0.60% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.27Based on 7 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.17 out of 5 stars 3.5 Analyst's Opinion Consensus RatingKnow Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageKnow Labs has only been the subject of 1 research reports in the past 90 days.Read more about Know Labs' stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.60% of the float of Know Labs has been sold short.Short Interest Ratio / Days to CoverKnow Labs has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Know Labs has recently decreased by 11.28%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldKnow Labs does not currently pay a dividend.Dividend GrowthKnow Labs does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for KNW. Previous Next 1.8 News and Social Media Coverage News SentimentKnow Labs has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.48 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Know Labs this week, compared to 1 article on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Know Labs insiders have not sold or bought any company stock.Percentage Held by Insiders13.70% of the stock of Know Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 23.96% of the stock of Know Labs is held by institutions.Read more about Know Labs' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Know Labs is -1.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Know Labs is -1.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioKnow Labs has a P/B Ratio of 13.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit About Know Labs Stock (NYSEAMERICAN:KNW)Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was incorporated in 1998 and is based in Seattle, Washington.Read More KNW Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KNW Stock News HeadlinesMay 19 at 12:01 PM | insidermonkey.comKnow Labs, Inc. (NYSE:KNW) Q2 2024 Earnings Call TranscriptMay 16, 2024 | msn.comHow a Texas-based lab is helping fight a ‘silent mass disaster’ in TennesseeMay 16, 2024 | businesswire.comKnow Labs Appoints Chris Somogyi as President, InternationalMay 16, 2024 | finance.yahoo.comKnow Labs Inc (KNW) Q2 2024 Earnings Call Transcript Highlights: Strategic Developments Amid ...May 15, 2024 | finance.yahoo.comKnow Labs, Inc. Reports Second Quarter FY 2024 ResultsMay 15, 2024 | businesswire.comKnow Labs, Inc. Reports Second Quarter FY 2024 ResultsMay 8, 2024 | businesswire.comKnow Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024May 7, 2024 | msn.comSmart labs for bespoke synthesis of nanomaterials are emergingApril 27, 2024 | venturebeat.comYoneda Labs raises $4M from Khosla Ventures to build the ‘OpenAI for chemistry’April 5, 2024 | businesswire.comKnow Labs to Present Clinical Research at the 2024 American Physiology SummitMarch 8, 2024 | stockhouse.comKnow Labs' Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research StudyMarch 6, 2024 | finance.yahoo.comKnow Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research StudyMarch 2, 2024 | uk.investing.comKnow Labs secures $12 million investment from LindFebruary 29, 2024 | msn.comKnow Labs secures $12M funding for further execution on clinical research and development initiativesFebruary 29, 2024 | finance.yahoo.comKnow Labs Secures U.S. $12 Million Funding for Company’s Further Execution on Its Clinical Research and Development InitiativesFebruary 29, 2024 | businesswire.comKnow Labs Secures U.S. $12 Million Funding for Company's Further Execution on Its Clinical Research and Development InitiativesFebruary 27, 2024 | stockhouse.comKnow Labs Announces the KnowU(TM), its Wearable Non-Invasive Continuous Glucose MonitorFebruary 27, 2024 | businesswire.comKnow Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose MonitorFebruary 15, 2024 | msn.comKnow Labs, Inc. (NYSE:KNW) Q1 2024 Earnings Call TranscriptFebruary 14, 2024 | finance.yahoo.comKnow Labs, Inc. Reports First Quarter FY2024 ResultsFebruary 14, 2024 | businesswire.comKnow Labs, Inc. Reports First Quarter FY2024 ResultsFebruary 7, 2024 | finance.yahoo.comKnow Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024February 5, 2024 | msn.comWestern North Carolina lab begins testing for 'gas station heroin' on the heels of FDA warningJanuary 24, 2024 | msn.comCity of Reedley, Fresno County to receive $260K for illegal lab cleanupJanuary 23, 2024 | finance.yahoo.comKnow Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)See More Headlines Receive KNW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Know Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/20/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorBusiness Services Industry Measuring & controlling devices, not elsewhere classified Sub-IndustryN/A Current SymbolNYSEAMERICAN:KNW CUSIPN/A CIKN/A Webwww.knowlabs.co Phone(206) 903-1351Fax206-826-0451Employees12Year FoundedN/APrice Target and Rating Average Stock Price Target$1.00 High Stock Price Target$1.00 Low Stock Price Target$1.00 Potential Upside/Downside+51.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.34) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-15,290,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-1,011.69% Return on Assets-175.06% Debt Debt-to-Equity RatioN/A Current Ratio0.93 Quick Ratio0.93 Sales & Book Value Annual Sales$4.36 million Price / Sales12.94 Cash FlowN/A Price / Cash FlowN/A Book Value$0.05 per share Price / Book13.20Miscellaneous Outstanding Shares85,510,000Free Float73,797,000Market Cap$56.44 million OptionableNot Optionable Beta1.54 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Ronald P. Erickson J.D. (Age 80)Founder, CEO, Treasurer & Chairman Comp: $544.97kMr. Peter Joseph ConleyCFO & Senior VP of Intellectual PropertyMs. Jessica English (Age 38)Chief Marketing Officer Dr. James H. Anderson Jr.M.D., Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory BoardMr. Steven T. KentChief Product OfficerMr. Leonardo Trautwein (Age 42)Chief Commercial Officer Jordyn HujarChief of StaffMore ExecutivesKey CompetitorsAutoscope TechnologiesNASDAQ:AATCOwletNYSE:OWLTGivBuxOTCMKTS:GBUXAlpha Technology GroupNASDAQ:ATGLDirect DigitalNASDAQ:DRCTView All CompetitorsInstitutional OwnershipPFG Investments LLCBought 179,977 shares on 4/22/2024Ownership: 0.221%Foguth Wealth Management LLC.Bought 95,790 shares on 4/17/2024Ownership: 0.118%View All Institutional Transactions KNW Stock Analysis - Frequently Asked Questions Should I buy or sell Know Labs stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Know Labs in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" KNW shares. View KNW analyst ratings or view top-rated stocks. What is Know Labs' stock price target for 2024? 1 Wall Street research analysts have issued 1-year price targets for Know Labs' stock. Their KNW share price targets range from $1.00 to $1.00. On average, they anticipate the company's share price to reach $1.00 in the next twelve months. This suggests a possible upside of 51.5% from the stock's current price. View analysts price targets for KNW or view top-rated stocks among Wall Street analysts. Are investors shorting Know Labs? Know Labs saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 341,500 shares, a drop of 11.3% from the April 15th total of 384,900 shares. Based on an average daily volume of 117,800 shares, the days-to-cover ratio is presently 2.9 days. Currently, 0.6% of the shares of the company are sold short. View Know Labs' Short Interest. Who are Know Labs' major shareholders? Know Labs' stock is owned by many different institutional and retail investors. Top institutional shareholders include PFG Investments LLC (0.22%) and Foguth Wealth Management LLC. (0.12%). Insiders that own company stock include Ichiro John Paul Takesako, Jessica English, Leonardo Mouta Trautwein, Ronald P Erickson and William Arthur Owens. View institutional ownership trends. How do I buy shares of Know Labs? Shares of KNW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:KNW) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold"The Biggest Drug Ever" Is ComingBehind the MarketsMost important medical advance in 100 yearsThe Oxford ClubDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Know Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
